Violence and abuse faced by junior physicians in the emergency department from patients and their caretakers: a nationwide study from pakistan.

Autor: Mirza NM (AUTHOR), Amjad AI (AUTHOR), Bhatti AB (AUTHOR), Tuz Zahra Mirza F (AUTHOR), Shaikh KS (AUTHOR), Kiani J (AUTHOR), Yusuf MM (AUTHOR), Khan MU (AUTHOR), Nazir ME (AUTHOR), Assad Q (AUTHOR), Humayun A (AUTHOR), Kiani IG (AUTHOR), Amjad SI (AUTHOR), Imam SZ (AUTHOR)

Publikováno v: Journal of Emergency Medicine (0736-4679). Jun2012, Vol. 42 Issue 6, p727-733. 7p.

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.

Autor: Kelly RJ; The Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA. ronan.kelly@bswhealth.org., Landon BV; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Zaidi AH; Allegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, USA., Singh D; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Canzoniero JV; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Balan A; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hales RK; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Voong KR; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Battafarano RJ; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Jobe BA; Allegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, USA., Yang SC; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Broderick S; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ha J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Marrone KA; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pereira G; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Rao N; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Borole A; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Karaindrou K; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Belcaid Z; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., White JR; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ke S; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Amjad AI; Allegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, USA., Weksler B; Allegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, USA., Shin EJ; Department of Gastroenterology & Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Thompson E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Smith KN; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pardoll DM; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hu C; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Feliciano JL; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Anagnostou V; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vanagno1@jhmi.edu.; The Bloomberg-Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vanagno1@jhmi.edu.; Lung Cancer Precision Medicine Center of Excellence, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vanagno1@jhmi.edu., Lam VK; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vklam@jhmi.edu.

Publikováno v: Nature medicine [Nat Med] 2024 Apr; Vol. 30 (4), pp. 1023-1034. Date of Electronic Publication: 2024 Mar 19.

CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells.

Autor: Sakao K; Department of Biochemical Science and Technology, Kagoshima University, Kagoshima City, Japan., Vyas AR; Department of Pharmacology and Chemical Biology, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Chinni SR; Departments of Urology and Pathology, and Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Amjad AI; Division of Hematology and Oncology, Department of Medicine, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Parikh R; Division of Hematology and Oncology, Department of Medicine, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Singh SV; Department of Pharmacology and Chemical Biology, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. singhs@upmc.edu.

Publikováno v: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2015 May; Vol. 8 (5), pp. 365-74. Date of Electronic Publication: 2015 Feb 23.

Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy.

Autor: Amjad AI; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA., Ali H; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA., Appleman LJ; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA., Maranchie J; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA., Jackman S; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA., Parwani A; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA., Dhir R; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA., Roy S; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA., Parikh RA; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA.

Publikováno v: Case reports in oncological medicine [Case Rep Oncol Med] 2014; Vol. 2014, pp. 615895. Date of Electronic Publication: 2014 Aug 19.

Breast Mass and Lytic Bone Lesions: A Rare Presentation of Non-Hodgkin's Lymphoma Arising in the Breast.

Autor: Ali H; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh Medical Centre, Pittsburgh, PA 15213, USA., Yeku O, Giesler D, Campbell-Massa R, Gao F, Amjad AI

Publikováno v: Case reports in oncological medicine [Case Rep Oncol Med] 2013; Vol. 2013, pp. 547171. Date of Electronic Publication: 2013 Oct 21.